Back to CLDX
MARSHALL WACE, LLP CLDX Position History
Celldex Therapeutics, Inc.
Quarters held
8
Latest value
$9.4M
Q3 2024
Peak value
$51M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $11.7M |
| Q1 2023 | $259K |
| Q2 2023 | $9.8M |
| Q3 2023 | $14.8M |
| Q4 2023 | $50.8M |
| Q1 2024 | $37.7M |
| Q2 2024 | $51M |
| Q3 2024 | $9.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2024 | $9.4M | 276.7K | — | — |
| Q2 2024 | $51M | 1.38M | — | — |
| Q1 2024 | $37.7M | 898.8K | — | — |
| Q4 2023 | $50.8M | 1.28M | — | — |
| Q3 2023 | $14.8M | 538.3K | — | — |
| Q2 2023 | $9.8M | 289.5K | — | — |
| Q1 2023 | $259K | 7.2K | — | — |
| Q1 2023 | $11.7M | 326.5K | — | — |